Sequential methotrexate-5-FU-leucovorin (MFL) in advanced colorectal cancer
- 1 March 1986
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (3) , 295-300
- https://doi.org/10.1016/0277-5379(86)90394-9
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Activity of sequential low-dose methotrexate and fluorouracil in advanced colorectal carcinoma: attempt at correlation with tissue and blood levels of phosphoribosylpyrophosphate.Journal of Clinical Oncology, 1984
- The enhancement of 5-fluorouracil antimetabolic activity by leucovorin, menadione and α-tocopherolEuropean Journal of Cancer and Clinical Oncology, 1982
- The influence of methotrexate pretreatment on 5-fluorouracil metabolism in L1210 cells.Journal of Biological Chemistry, 1981
- EFFECT OF EXCESS FOLATES AND DEOXYINOSINE ON THE ACTIVITY AND SITE OF ACTION OF 5-FLUOROURACIL1981
- MODULATION OF 5-FLUOROURACIL METABOLISM AND CYTO-TOXICITY BY ANTI-METABOLITE PRETREATMENT IN HUMAN COLORECTAL ADENOCARCINOMA HCT-81981
- Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug SynergismScience, 1979
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977
- SCHEDULE-DEPENDENT ANTITUMOR EFFECTS OF METHOTREXATE AND 5-FLUOROURACIL1977